Here's the Dark Horse in the COVID Vaccine Race That You'll Want to Watch

Here's the Dark Horse in the COVID Vaccine Race That You'll Want to Watch

Pfizer and BioNTech have already won authorization in the U.K. for their vaccine, BNT162b2, which could receive U.S. emergency use authorization within weeks. Johnson & Johnson should announce interim late-stage study results for its vaccine candidate JNJ-78436735 in early 2021. Arcturus is currently evaluating COVID-19 vaccine candidate ARCT-021 in a phase 1/2 clinical study.